The effect of diosmin on the pharmacokinetics of fexofenadine in healthy human volunteers-Reference-Cited by-同舟云学术

The effect of diosmin on the pharmacokinetics of fexofenadine in healthy human volunteers

Published:2016-05-06 Issue:3 Volume:47 Page:230-235
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Bedada Satish Kumar¹,Boga Praveen Kumar¹,Kotakonda Harish Kaushik¹

Affiliation:

1. Drug Metabolism and Pharmacokinetics Division, University College of Pharmaceutical Sciences, Kakatiya University, Warangal, Telangana State, India

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/00498254.2016.1180564

Reference37 articles.

1. BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER

2. Resveratrol Enhances the Bioavailability of Fexofenadine in Healthy Human Male Volunteers: Involvement of P-Glycoprotein Inhibition

3. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients

4. OATP and P-Glycoprotein Transporters Mediate the Cellular Uptake and Excretion of Fexofenadine

5. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Pharmacokinetics of Fexofenadine: A Systematic Review;Pharmaceutics;2024-12-20

2. Revisiting diosmin for their potential biological properties and applications;Carbohydrate Polymer Technologies and Applications;2024-06

3. Effect of Diosmin on Pharmacokinetics and Pharmacodynamics of Rivaroxaban in Rats;Current Pharmaceutical Analysis;2024-04

4. Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic Drugs;Pharmaceutics;2023-03-18

5. Fexofenadine Plasma Concentrations to Estimate Systemic Exposure in Healthy Adults Using a Limited Sampling Strategy with a Population Pharmacokinetic Approach;Therapeutic Drug Monitoring;2023-01-13